Augmentation versus inhibition: effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples